Altox

Database / API & reference standards

API & reference standards

Osimertinib

Osimertinib is listed in the API and reference-standard collection under CAS 1421373-65-0. Its represented structure has formula C28H33N7O2 and a calculated molecular weight of 499.62 g/mol.

2D chemical structure

O H N N H N N N O N N

Chemical identity

Catalog name
Osimertinib
Common name
Osimertinib
Chemical name
N-[2-[2-(dimethylamino)ethyl-methylamino]-4-methoxy-5-[[4-(1-methylindol-3-yl)pyrimidin-2-yl]amino]phenyl]prop-2-enamide
CAS
1421373-65-0
SMILES
C=CC(=O)Nc1cc(Nc2nccc(-c3cn(C)c4ccccc34)n2)c(OC)cc1N(C)CCN(C)C
InChI
InChI=1S/C28H33N7O2/c1-7-27(36)30-22-16-23(26(37-6)17-25(22)34(4)15-14-33(2)3)32-28-29-13-12-21(31-28)20-18-35(5)24-11-9-8-10-19(20)24/h7-13,16-18H,1,14-15H2,2-6H3,(H,30,36)(H,29,31,32)
InChIKey
DUYJMQONPNNFPI-UHFFFAOYSA-N
Associated API
AZD9291 | Osimertinib Mesilate

Record ID: A6630f4a57e4e

Computed properties

C28H33N7O2 Molecular formula
499.619 g/molMolecular weight
499.2696 DaMonoisotopic exact mass
87.55 ŲTopological polar surface area
4.5098 Calculated LogP (Wildman–Crippen)
150.8724 cm³/molMolar refractivity (Wildman–Crippen)
7 countHydrogen-bond acceptors
2 countHydrogen-bond donors

Descriptors are calculated from the displayed SMILES. Calculated LogP is not a measured partition coefficient or a pH-specific LogD.

Molecular descriptor profile

Descriptor radar

Mol. weight LogP TPSA HBA HBD Rotatable 25 50 75 100

Structural feature counts

0 3 6 9 Count H-bond acceptors H-bond donors Rotatable bonds Rings Aromatic rings Stereo centers

Element composition

C H N O 0 8 16 24 32 Number of atoms

Radar scale: 0–100 percentile within 25,771 distinct represented structures in this release, using the midpoint rank for ties. Larger values indicate a higher descriptor rank, not greater safety or toxicity. Element counts include hydrogen and combine isotopes under each element.

Radar values and percentile reference
DescriptorValuePercentile
Molecular weight499.61985.04
Calculated LogP (Wildman–Crippen)4.509884.76
Topological polar surface area87.5563.71
Hydrogen-bond acceptors783.12
Hydrogen-bond donors264.87
Rotatable bonds (strict)1089.42

Complete molecular descriptors

PropertyCalculated valueUnit / type
Molecular formulaC28H33N7O2dimensionless
Molecular weight499.619g/mol
Monoisotopic exact mass499.2696Da
Topological polar surface area87.55Ų
Calculated LogP (Wildman–Crippen)4.5098dimensionless
Molar refractivity (Wildman–Crippen)150.8724cm³/mol
Hydrogen-bond acceptors7count
Hydrogen-bond donors2count
Rotatable bonds (strict)10count
Heavy atoms37count
Heteroatoms9count
Rings4count
Aromatic rings4count
Aliphatic rings0count
Saturated rings0count
Aromatic heterocycles2count
Aliphatic heterocycles0count
Saturated heterocycles0count
Aromatic carbocycles2count
Aliphatic carbocycles0count
Fraction of sp³ carbon atoms0.25fraction
Formal charge0e
Disconnected components1count
Isotopically specified atoms0count
Potential atom stereocenters0count
Unspecified atom stereocenters0count
Spiro atoms0count
Bridgehead atoms0count
Labute approximate surface area216.94Ų
Valence electrons192count
Radical electrons0count
Bertz complexity1,427.5756index
Balaban J1.7066index

Ring categories overlap and should not be summed. No toxicity result, PDE, HBEL or acceptable intake is inferred from these descriptors.

Toxicological services and resources for Osimertinib

PDE, HBEL and impurity assessment for Osimertinib

For a substance-specific assessment, request a PDE report for Osimertinib or explore HBEL derivation for Osimertinib. These services address exposure limits using toxicological evidence and the intended use of the substance.

For pharmaceutical development, explore prediction of degradation products of Osimertinib and qualification of impurities related to Osimertinib.

Related Altox services and technical resources

Identity sources and calculation method

Identifiers originate from the source catalogues and available public identity records. InChI and InChIKey on this page are generated from the displayed SMILES. RDKit validation checks the molecular representation; it does not independently verify every catalogue assignment.

Discuss an assessment for Osimertinib

Explore Altox services and software through the Altox Pharma-Hub.